{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:29:14Z","timestamp":1788226154228,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Gutenberg-Universit\u00e4t Mainz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Im Kontext von Kopfschmerzerkrankungen beschreibt der Begriff \u201eAttackenangst\u201c die Furcht vor dem Auftreten einer Kopfschmerzattacke. Ein \u00dcberma\u00df an Attackenangst kann sich ung\u00fcnstig auf den Krankheitsverlauf bei Migr\u00e4ne auswirken und zu einer Verst\u00e4rkung der Migr\u00e4neaktivit\u00e4t f\u00fchren. Zur Diagnostik von Attackenangst stehen der kategoriale Ansatz (Attackenangst als spezifische Phobie) sowie der dimensionale Ansatz (Erfassung des Angstausma\u00dfes mittels Selbstbeurteilungsfragebogen) zur Verf\u00fcgung. Als Selbstbeurteilungsfragebogen liegt mit dem 29\u00a0Items umfassenden <jats:italic>Fragebogen zur Attackenangst bei Migr\u00e4ne<\/jats:italic> (FAMI) ein \u00f6konomisches Messinstrument mit guten psychometrischen Eigenschaften vor. Zur Behandlung von Attackenangst bei Migr\u00e4ne existieren neben medikament\u00f6sen Ma\u00dfnahmen auch gezielte verhaltenstherapeutische Interventionen. Die nebenwirkungsarmen verhaltenstherapeutischen Interventionen sind an die Behandlung von g\u00e4ngigen Angstst\u00f6rungen (z.\u202fB. Agoraphobie) angelehnt. Ein Wirksamkeitsnachweis f\u00fcr spezifische Interventionen zur Behandlung von Attackenangst bei Migr\u00e4ne steht noch aus. Im Rahmen der Kopfschmerzanamnese und -behandlung sollte Attackenangst dennoch adressiert werden.<\/jats:p>","DOI":"10.1007\/s00482-023-00711-y","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T17:02:33Z","timestamp":1681837353000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Attackenangst bei Migr\u00e4ne: Diagnostik und Behandlung","Fear of migraine attacks: diagnosis and treatment"],"prefix":"10.1007","volume":"39","author":[{"given":"Timo","family":"Klan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Diezemann-Pr\u00f6\u00dfdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Witth\u00f6ft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"711_CR1","volume-title":"Diagnostic and statistical manual of mental disorders. DSM-IV","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. DSM-IV, 4.\u00a0Aufl. American Psychiatric Association, Washington","edition":"4"},{"key":"711_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"AP Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Washington"},{"key":"711_CR3","unstructured":"Bandelow\u00a0B, Aden\u00a0I, Alpers\u00a0G et al (2021) Deutsche S3-Leitlinie Behandlung von Angstst\u00f6rungen. Version 2. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/051-028l_S3_Behandlung-von-Angststoerungen_2021-06.pdf. Zugegriffen: 7. Nov. 2022"},{"key":"711_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","volume":"21","author":"DC Buse","year":"2020","unstructured":"Buse\u00a0DC, Reed\u00a0ML, Fanning\u00a0KM et al (2020) Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J\u00a0Headache Pain 21:23. https:\/\/doi.org\/10.1186\/s10194-020-1084-y","journal-title":"J Headache Pain"},{"key":"711_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","volume":"17","author":"A Charles","year":"2018","unstructured":"Charles\u00a0A (2018) The pathophysiology of migraine: implications for clinical management. Lancet Neurol 17:174\u2013182. https:\/\/doi.org\/10.1016\/S1474-4422(17)30435-0","journal-title":"Lancet Neurol"},{"key":"711_CR6","doi-asserted-by":"crossref","unstructured":"Diener H\u2011C, F\u00f6rderreuther S, Kropp P (2022) Therapie der Migr\u00e4neattacke und Prophylaxe der Migr\u00e4ne. S1-Leitlinie. https:\/\/dgn.org\/leitlinie\/214. Zugegriffen: 13. Jan. 2023","DOI":"10.1007\/s42451-023-00550-2"},{"key":"711_CR7","first-page":"111","volume-title":"Multimodale Schmerztherapie bei chronischen Kopfschmerzen. Interdisziplin\u00e4re Behandlungskonzepte","author":"A Diezemann","year":"2013","unstructured":"Diezemann\u00a0A (2013) 4.3 Kognitive Techniken. In: Fritsche\u00a0G, Gaul\u00a0C (Hrsg) Multimodale Schmerztherapie bei chronischen Kopfschmerzen. Interdisziplin\u00e4re Behandlungskonzepte. Thieme, Stuttgart, S\u00a0111\u2013119"},{"key":"711_CR8","volume-title":"Taschenf\u00fchrer zur ICD-10-Klassifikation psychischer St\u00f6rungen. Mit Glossar und diagnostischen Kriterien sowie Referenztabellen ICD-10 vs. ICD-9 und ICD-10 vs. DSM-IV-TR","year":"2014","unstructured":"Dilling\u00a0H, Freyberger\u00a0HJ (Hrsg) (2014) Taschenf\u00fchrer zur ICD-10-Klassifikation psychischer St\u00f6rungen. Mit Glossar und diagnostischen Kriterien sowie Referenztabellen ICD-10 vs. ICD\u20119 und ICD-10 vs. DSM-IV-TR. 7., \u00fcberarb. Aufl. unter Ber\u00fccksichtigung der \u00c4nderungen entsprechend ICD-10-GM (German Modification) 2014. Huber, Bern","edition":"7"},{"key":"711_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-019-0988-x","volume":"20","author":"T Dresler","year":"2019","unstructured":"Dresler\u00a0T, Caratozzolo\u00a0S, Guldolf\u00a0K et\u00a0al (2019) Understanding the nature of psychiatric comorbidity in migraine: a\u00a0systematic review focused on interactions and treatment implications. J\u00a0Headache Pain 20:51. https:\/\/doi.org\/10.1186\/s10194-019-0988-x","journal-title":"J Headache Pain"},{"key":"711_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00482-020-00507-4","volume":"34","author":"T Dresler","year":"2020","unstructured":"Dresler\u00a0T, Guth\u00a0A\u2011L, L\u00fcpke\u00a0J et al (2020) Psychologische Kopfschmerztherapie in Zeiten von COVID-19. Schmerz 34:503\u2013510. https:\/\/doi.org\/10.1007\/s00482-020-00507-4","journal-title":"Schmerz"},{"key":"711_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pain.2010.07.032","volume":"151","author":"G Fritsche","year":"2010","unstructured":"Fritsche\u00a0G, Frettl\u00f6h\u00a0J, H\u00fcppe\u00a0M et\u00a0al (2010) Prevention of medication overuse in patients with migraine. Pain 151:404\u2013413. https:\/\/doi.org\/10.1016\/j.pain.2010.07.032","journal-title":"Pain"},{"key":"711_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1129-2377-14-49","volume":"14","author":"G Giannini","year":"2013","unstructured":"Giannini\u00a0G, Zanigni\u00a0S, Grimaldi\u00a0D et al (2013) Cephalalgiaphobia as a\u00a0feature of high-frequency migraine: a\u00a0pilot study. J\u00a0Headache Pain 14:49. https:\/\/doi.org\/10.1186\/1129-2377-14-49","journal-title":"J Headache Pain"},{"key":"711_CR13","unstructured":"Gray E (2022) Migraine and anxiety in the context of the Covid-19 pandemic. Honors theses. 2558. https:\/\/digitalworks.union.edu\/theses\/2558. Zugegriffen: 14. Febr. 2022"},{"key":"711_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"711_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/1745691611419671","volume":"6","author":"BK H\u00f6lzel","year":"2011","unstructured":"H\u00f6lzel\u00a0BK, Lazar\u00a0SW, Gard\u00a0T et\u00a0al (2011) How does mindfulness meditation work? Proposing mechanisms of action from a\u00a0conceptual and neural perspective. Perspect Psychol Sci 6:537\u2013559. https:\/\/doi.org\/10.1177\/1745691611419671","journal-title":"Perspect Psychol Sci"},{"key":"711_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archpsyc.1965.01720360001001","volume":"12","author":"FH Kanfer","year":"1965","unstructured":"Kanfer\u00a0FH, Saslow\u00a0G (1965) Behavioral analysis. An alternative to diagnostic classification. Arch Gen Psychiatry 12:529. https:\/\/doi.org\/10.1001\/archpsyc.1965.01720360001001","journal-title":"Arch Gen Psychiatry"},{"key":"711_CR17","doi-asserted-by":"publisher","first-page":"613372","DOI":"10.3389\/fneur.2020.613372","volume":"11","author":"L Karimi","year":"2020","unstructured":"Karimi\u00a0L, Wijeratne\u00a0T, Crewther\u00a0SG et al (2020) The migraine-anxiety comorbidity among migraineurs: a systematic review. Front Neurol 11:613372. https:\/\/doi.org\/10.3389\/fneur.2020.613372","journal-title":"Front Neurol"},{"key":"711_CR18","doi-asserted-by":"publisher","DOI":"10.1026\/02851-000","volume-title":"Kognitiv-verhaltenstherapeutisches Migr\u00e4nemanagement (MIMA). Ein Behandlungsmanual zur Krankheitsbew\u00e4ltigung und Attackenprophylaxe bei Migr\u00e4ne","author":"T Klan","year":"2020","unstructured":"Klan\u00a0T, Liesering-Latta\u00a0E (2020) Kognitiv-verhaltenstherapeutisches Migr\u00e4nemanagement (MIMA). Ein Behandlungsmanual zur Krankheitsbew\u00e4ltigung und Attackenprophylaxe bei Migr\u00e4ne. Hogrefe, G\u00f6ttingen"},{"key":"711_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/head.14272","volume":"62","author":"T Klan","year":"2022","unstructured":"Klan\u00a0T, Br\u00e4scher\u00a0A\u2011K, Klein\u00a0S et al (2022) Assessing attack-related fear in headache disorders-Structure and psychometric properties of the Fear of Attacks in Migraine Inventory. Headache 62:294\u2013305. https:\/\/doi.org\/10.1111\/head.14272","journal-title":"Headache"},{"key":"711_CR20","doi-asserted-by":"publisher","first-page":"852616","DOI":"10.3389\/fneur.2022.852616","volume":"13","author":"T Klan","year":"2022","unstructured":"Klan\u00a0T, Gaul\u00a0C, Liesering-Latta\u00a0E et al (2022) Efficacy of cognitive-behavioral therapy for the prophylaxis of migraine in adults: a three-armed randomized controlled trial. Front Neurol 13:852616. https:\/\/doi.org\/10.3389\/fneur.2022.852616","journal-title":"Front Neurol"},{"key":"711_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-clinpsy-081219-093304","volume":"17","author":"R Kotov","year":"2021","unstructured":"Kotov\u00a0R, Krueger\u00a0RF, Watson\u00a0D et\u00a0al (2021) The hierarchical taxonomy of psychopathology (HiTOP): a quantitative nosology based on consensus of evidence. Annu Rev Clin Psychol 17:83\u2013108. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081219-093304","journal-title":"Annu Rev Clin Psychol"},{"key":"711_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12529-014-9426-2","volume":"22","author":"N Kreddig","year":"2015","unstructured":"Kreddig\u00a0N, Rusu\u00a0AC, Burkhardt\u00a0K et al (2015) The German PASS-20 in patients with low back pain: New aspects of convergent, divergent, and criterion-related validity. Int J Behav Med 22:197\u2013205. https:\/\/doi.org\/10.1007\/s12529-014-9426-2","journal-title":"Int J Behav Med"},{"key":"711_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-020-01037-3","volume":"20","author":"J Lai","year":"2020","unstructured":"Lai\u00a0J, Dilli\u00a0E (2020) Migraine aura: Updates in pathophysiology and management. Curr Neurol Neurosci Rep 20:17. https:\/\/doi.org\/10.1007\/s11910-020-01037-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"711_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti\u00a0P, Schwedt\u00a0TJ, Lanteri-Minet\u00a0M et al (2018) My Migraine Voice survey: a\u00a0global study of disease burden among individuals with migraine for whom preventive treatments have failed. J\u00a0Headache Pain 19:115. https:\/\/doi.org\/10.1186\/s10194-018-0946-z","journal-title":"J Headache Pain"},{"key":"711_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11916-010-0112-z","volume":"14","author":"PR Martin","year":"2010","unstructured":"Martin\u00a0PR (2010) Behavioral management of migraine headache triggers. Learning to cope with triggers. Curr Pain Headache Rep 14:221\u2013227. https:\/\/doi.org\/10.1007\/s11916-010-0112-z","journal-title":"Curr Pain Headache Rep"},{"key":"711_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11916-016-0576-6","volume":"20","author":"PR Martin","year":"2016","unstructured":"Martin\u00a0PR (2016) Stress and primary headache. Review of the research and clinical management. Curr Pain Headache Rep 20:45. https:\/\/doi.org\/10.1007\/s11916-016-0576-6","journal-title":"Curr Pain Headache Rep"},{"key":"711_CR27","series-title":"Fortschritte der Psychotherapie","volume-title":"Achtsamkeit","author":"J Michalak","year":"2012","unstructured":"Michalak\u00a0J, Heidenreich\u00a0T, Williams\u00a0JMG (2012) Achtsamkeit. Fortschritte der Psychotherapie, Bd. 48. Hogrefe, G\u00f6ttingen"},{"key":"711_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417727535","author":"ABW Pellegrino","year":"2017","unstructured":"Pellegrino\u00a0ABW, Davis-Martin\u00a0RE, Houle\u00a0TT et al (2017) Perceived triggers of primary headache disorders. A meta-analysis. Cephalalgia. https:\/\/doi.org\/10.1177\/0333102417727535","journal-title":"Cephalalgia"},{"key":"711_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10194-007-0361-3","volume":"8","author":"MFP Peres","year":"2007","unstructured":"Peres\u00a0MFP, Mercante\u00a0JPP, Guendler\u00a0VZ et\u00a0al (2007) Cephalalgiaphobia: a\u00a0possible specific phobia of illness. J\u00a0Headache Pain 8:56\u201359. https:\/\/doi.org\/10.1007\/s10194-007-0361-3","journal-title":"J Headache Pain"},{"key":"711_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.25646\/6990.2","volume":"5","author":"M Porst","year":"2020","unstructured":"Porst\u00a0M, Wengler\u00a0A, Leddin\u00a0J et al (2020) Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study. J\u00a0Health Monit 5:2\u201324. https:\/\/doi.org\/10.25646\/6990.2","journal-title":"J Health Monit"},{"key":"711_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-2982.2008.01644.x","volume":"28","author":"F Radat","year":"2008","unstructured":"Radat\u00a0F, Mekies\u00a0C, G\u00e9raud\u00a0G et\u00a0al (2008) Anxiety, stress and coping behaviours in primary care migraine patients: results of the SMILE study. Cephalalgia 28:1115\u20131125. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01644.x","journal-title":"Cephalalgia"},{"key":"711_CR32","doi-asserted-by":"publisher","DOI":"10.1026\/02664-000","volume-title":"Verhaltensanalyse. Ein Praxisleitfaden","author":"H Reinecker","year":"2015","unstructured":"Reinecker\u00a0H (2015) Verhaltensanalyse. Ein Praxisleitfaden, 1.\u00a0Aufl. Hogrefe, G\u00f6ttingen","edition":"1"},{"key":"711_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-019-0962-7","volume":"20","author":"R Ruscheweyh","year":"2019","unstructured":"Ruscheweyh\u00a0R, Pereira\u00a0D, Hasenbring\u00a0MI et al (2019) Pain-related avoidance and endurance behaviour in migraine: an observational study. J\u00a0Headache Pain 20:9. https:\/\/doi.org\/10.1186\/s10194-019-0962-7","journal-title":"J Headache Pain"},{"key":"711_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-018-0865-z","volume":"19","author":"TJ Schwedt","year":"2018","unstructured":"Schwedt\u00a0TJ, Alam\u00a0A, Reed\u00a0ML et\u00a0al (2018) Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J\u00a0Headache Pain 19:38. https:\/\/doi.org\/10.1186\/s10194-018-0865-z","journal-title":"J Headache Pain"},{"key":"711_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0269881115612236","volume":"30","author":"SA Steenen","year":"2016","unstructured":"Steenen\u00a0SA, van Wijk\u00a0AJ, van der Heijden\u00a0GJMG et al (2016) Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. J\u00a0Psychopharmacol 30:128\u2013139. https:\/\/doi.org\/10.1177\/0269881115612236","journal-title":"J Psychopharmacol"},{"key":"711_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/head.14411","volume":"62","author":"LY Thaxter","year":"2022","unstructured":"Thaxter\u00a0LY, Smitherman\u00a0TA (2022) The effect of the COVID-19 pandemic on headache-related disability among young adults with migraine. Headache 62:1293\u20131301. https:\/\/doi.org\/10.1111\/head.14411","journal-title":"Headache"},{"key":"711_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s10194-018-0875-x","volume":"19","author":"N Vandenbussche","year":"2018","unstructured":"Vandenbussche\u00a0N, Laterza\u00a0D, Lisicki\u00a0M et al (2018) Medication-overuse headache: a\u00a0widely recognized entity amidst ongoing debate. J\u00a0Headache Pain 19:50. https:\/\/doi.org\/10.1186\/s10194-018-0875-x","journal-title":"J Headache Pain"},{"key":"711_CR38","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/j.pain.0000000000000574","volume":"157","author":"JWS Vlaeyen","year":"2016","unstructured":"Vlaeyen\u00a0JWS, Crombez\u00a0G, Linton\u00a0SJ (2016) The fear-avoidance model of pain. Pain 157:1588\u20131589. https:\/\/doi.org\/10.1097\/j.pain.0000000000000574","journal-title":"Pain"},{"key":"711_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos\u00a0T, Abajobir\u00a0AA, Abate\u00a0KH et\u00a0al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195\u00a0countries, 1990\u20132016. A systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"key":"711_CR40","series-title":"Therapie-Tools","volume-title":"Therapie-Tools Akzeptanz- und Commitmenttherapie (ACT)","author":"M Wengenroth","year":"2017","unstructured":"Wengenroth\u00a0M (2017) Therapie-Tools Akzeptanz- und Commitmenttherapie (ACT), 2.\u00a0Aufl. Therapie-Tools. Beltz, Weinheim, Basel (Mit E\u2011Book inside und Arbeitsmaterial)","edition":"2"},{"key":"711_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"372","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel\u00a0YW, Cowan\u00a0RP (2017) Migraine affects 1 in 10 people worldwide featuring recent rise. A systematic review and meta-analysis of community-based studies involving 6\u00a0million participants. J\u00a0Neurol Sci 372:307\u2013315. https:\/\/doi.org\/10.1016\/j.jns.2016.11.071","journal-title":"J Neurol Sci"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-023-00711-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-023-00711-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-023-00711-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:47:24Z","timestamp":1747903644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-023-00711-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s00482-023-00711-y","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.-L.\u00a0Guth hat Honorar f\u00fcr Beratung und Vortr\u00e4ge innerhalb der letzten drei Jahre von den folgenden Firmen erhalten: Allergan\/AbbVie, Hormosan Pharma, Lundbeck, Ratiopharm und TEVA. C. Gaul hat Honorar f\u00fcr Beratung und Vortr\u00e4ge innerhalb der letzten drei Jahre von den folgenden Firmen erhalten: AbbVie, Lilly, Novartis Pharma, Hormosan Pharma, Gr\u00fcnenthal, Sanofi-Aventis, Reckitt, Lundbeck, Perfood und TEVA. C. Gaul ist Generalsekret\u00e4r der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft (DMKG) e.\u202fV. T.\u00a0Klan, A.\u00a0Diezemann-Pr\u00f6\u00dfdorf und M.\u00a0Witth\u00f6ft geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}